Institution
Yuhuangding Hospital
Also known as: Yantai Yuhuangding Hospital · 烟台毓璜顶医院
- 83running trials
- 28closed trials
- 8,223publications (OpenAlex)
Running trials
Not yet recruiting
Recruiting
Not yet recruiting
Recruiting
Efficacy and Safety of Telitacicept in the Treatment of Refractory Rheumatoid Arthritis
Recruiting
Recruiting
Non-stenting Treatment Strategy for Acute Myocardial Infarction With Non-severe Stenosis(EROSION IV)
Recruiting
Not yet recruiting
Not yet recruiting
Ongericimab Injection Reducing Recurrence of Ischemic Stroke
Recruiting
A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
Recruiting
Recruiting
Recruiting
Enrolling by invitation
China-NINE Cohort:Neuroimmune Network in Elderly / Neurodegeneration
Recruiting
Multi-Center Study of Natural History in Atypical Parkinsonian Syndromes (MAPS-NH)
Recruiting
Recruiting
A Phase II Study of Tislelizumab Plus Anlotinib Consolidation After Chemoradiotherapy in LS-SCLC
Not yet recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Clinical Trial of TQC2731 Injection in Patients With Chronic Sinusitis and Nasal Polyps
Recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
TQC2731 Clinical Trial for the Treatment of Severe Asthma With Injection
Recruiting
Recruiting
Not yet recruiting
A Clinical Study of SCTC21C in Participants With Plasma Cell-driven Autoimmune Diseases
Active, not recruiting
Camrelizumab Combined With or Without Apatinib and SOX of Neoadjuvant Treatment for Gastric Cancer
Active, not recruiting
Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML
Active, not recruiting
Active, not recruiting
Recruiting
First-line Treatment With RC48 Plus Sintilimab and S-1 in Advanced Gastric Cancer (RCTS2)
Recruiting
Active, not recruiting
Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)
Recruiting
A Clinical Study of B007 in the Treatment of Primary Membranous Nephropathy.
Recruiting
Not yet recruiting
Anlotinib Hydrochloride Capsules Combined With TQB2450 in the Treatment of Endometrial Cancer
Active, not recruiting
Recruiting
Preventive Drug-coated Balloon Angioplasty in Vulnerable Atherosclerotic Plaque (RESTORE Trial)
Active, not recruiting
Postoperative Adjuvant Therapy for Stage II-III Gastric Cancer
Recruiting
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
Showing 50 of 83.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Gastric and oesophageal cancer5 recruiting
- Colorectal cancer4 recruiting
- Coronary artery disease4 recruiting
- Prostate cancer4 recruiting
- Endometrial cancer3 recruiting
- Lung cancer3 recruiting
- Alzheimer disease2 recruiting
- Asthma2 recruiting
- Bladder cancer2 recruiting
- Chronic kidney disease2 recruiting
- COPD2 recruiting
- IgA nephropathy2 recruiting
- Stroke2 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Follicular lymphoma1 recruiting
- Head and neck cancer1 recruiting
- Hodgkin lymphoma1 recruiting
- Lewy body dementia1 recruiting
- Lupus (SLE)1 recruiting
- Metastatic breast cancer1 recruiting
- Multiple system atrophy1 recruiting
- Ovarian cancer1 recruiting
- Parkinson disease1 recruiting
- Rheumatoid arthritis1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Completed
Withdrawn
Efficacy and Safety of Volenrelaxin in Adults With Chronic Kidney Disease
Completed
Completed
Completed
Recruiting
A Study of Vedolizumab in Adult Participants With Moderate to Severe Crohn's Disease
Completed
HPP737 in Adult Patients With Moderate-to-severe Plaque Psoriasis.
Completed
Completed
rhPro-UK in Acute Ischaemic Stroke Within 4.5 Hours of Stroke Onset Trial 2(PROST-2)
Completed
Completed
ProUrokinase for Mild Ischemic Cerebrovascular Events (PUMICE)
Recruiting
Completed
Terminated
Completed
Completed
Study of KN046 in Subjects With Advanced Non-Small Cell Lung Cancer
Completed
Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Macular Degeneration
Completed
Telitacicept Study in Chinese Subjects With Systemic Lupus Erythematosus
Recruiting
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
Terminated
Completed
GB491 Combined With Fulvestrant for HR+ HER2- Locally Advanced or Metastatic Breast Cancer
Completed
Terminated
Terminated
Completed
Darolutamide in Addition to ADT Versus ADT in Metastatic Hormone-sensitive Prostate Cancer
Completed
Completed
Terminated
Registry name variants (6)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Yantai Yuhuangding Hospital
Yantai, Shandong 264000
106 trials
Department of Breast Surgery, Yantai Yuhuangding Hospital
Yantai, Shandong 264000
1 trial
Yantai Yuhuangding Hospital(Base Cpmpus)
Yantai, Shandong 264000
1 trial
Yantai Yuhuangding Hospital (Site 0397)
Yantai, Shandong 264099
1 trial
NCT06136624Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
Contact: Study Coordinator
Yantai Yuhuangding Hospital (Site 1622)
Yantai, Shandong 264099
1 trial
Yantai Yuhuangding Hospital - Site #41
Yantai, Shandong 264099
1 trial
Conditions
Diseases this institution publishes on or runs trials for.
- Bladder cancer27 works · 4 trials
- Kidney cancer25 works · 0 trials
- Chronic rhinosinusitis with nasal polyps7 works · 3 trials
Institution data: ROR 05vawe413 (CC0-1.0)Updated 15 Nov 2026